Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27(KIP1), in rat hearts during development

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 3, 1998, Pages 463-474

  Koh, Keum Nim ^a   Kang, Min Jeong ^a   Frith Terhune, Amy ^a   Park, Sung Kwang ^a   Kim, Injune ^b   Lee, Chin Ok ^b   Koh, Gou Young ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Cardiac development; Cardiomyocyte; Cell cycle; Cyclin dependent kinase inhibitor

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PROTEIN P21; PROTEIN P27;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVITY; GESTATION PERIOD; HEART DEVELOPMENT; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT;

EID: 0032032454     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0611     Document Type: Article

References (39)

1. ANVERSA P, OLIVETTI G, LOUD AV, 1980. Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. I. Hypertrophy, hyperplasia, and binucleation of myocytes. Circ Res 46: 495-502.
2. BRODSKY VYA, AREFYEVA AM, URYVAEVA IV, 1980. Mitotic polyploidization of mouse heart myocytes during the first postnatal week. Cell Tissue Res 210: 133-144.
3. CLAYCOMB WC, 1992. Control of cardiac muscle division. Trend Cardiovasc 2: 231-236.
4. CLUBB FJ JR, BISHOP SP, 1984. Formation of binucleated myocardial cells in the neonatal rat. Lab Invest 50: 571-577.
5. CIP/WAF1 undergo normal development but are defective in G1 checkpoint control. Cell 82: 675-684.
6. EL-DEIRY WS, TOKINO T, VELCULESCU VE, LEVY DB, PARSONS R, TRENT JM, LIN D, MERCER WE, KINZLER KW, VOGELSTEIN B, 1993. WAF-1 a potential mediator of p53 tumor suppression. Cell 75: 817-825.
7. EROKHINA IL, RUMYANTSEV PP, 1988. Proliferation and biosynthetic activities of myocytes from the conductive system and working myocardium of the developing mouse heart. Light microscopic autoradiographic study. Acta Histochem 84: 51-66.
8. KIP1-deficient mice. Cell 85: 733-744.
9. FORT P, MARTY L, PIECHACZYK M, SABROUTY SE, DANI C, JEANTEUR P, BLANCHARD JM, 1985. Various rat adult tissue express only major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13: 1431-1442.
10. HARPER JW, ELLEDGE SJ, 1996. CDK inhibitors in development and cancer. Curr Opin Genet Dev 6: 56-64.
11. KIP1 accumulation during the cell cycle. Science 271: 1861-1864.
12. HUNTER T, PINES J, 1991. Cyclins and cancer. Cell 66: 1071-1074.
13. HUNTER T, PINES J, 1994. Cyclins and cancer II: cyclin D and CDK inhibitors come to age. Cell 79: 573-582.
14. KANG MJ, KOH GY, 1997. Differential and dramatic changes of cyclin dependent kinase activities in cardiomyocytes during the neonatal period. J Mol Cell Cardiol 29: 1767-1777.
15. KIP1. Cell 85: 721-732.
16. LABAER J, GARRETT MD, STEPHENSON LF, SLINGERLAND JM, SANDHU C, CHOU HS, FATTAEY A, HARLOW E, 1997. New functional activities for the p21 family of CDK inhibitors. Gene Develop 11: 847-862.
17. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Gene Develop 9: 639-649.
18. LEES E, 1995. Cyclin dependent kinase regulation. Current Opinion Cell Biol 7: 773-780.
19. LI F, WANG X, CAPASSO JM, GERDES AM, 1996. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28: 1737-1746.
20. CIP1 CDK inhibitor family, is a candidate tumor suppressor gene. Gene Develop 9: 650-662.
21. MCGILL CJ, BROOKS G, 1995. Cell cycle control mechanisms and their role in cardiac growth. Cardiovasc Res 30: 557-569.
22. MORGAN DO, 1995. Principles of CDK regulation. Nature 374: 131-134.
23. MURRAY A, HUNT T, 1993. In: The Cell Cycle. New York: W.H. Freeman and Company.
24. KIP1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707-720.
25. OLIVETTI G, ANVERSA P, LOUD AV, 1980. Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. Circ Res 46: 503-512.
26. OPARIL S, BISHOP SP, CLUBB FJ JR, 1984. Myocardial cell hypertrophy and hyperplasia. Hypertension 6 (Suppl. III): III-38-III-43.
27. PAGANO M, TAM SW, THEODORAS AM, BEER-ROMERO P, SAL DG, CHAU V, YEW PR, DRAETTA GF, ROLFE M, 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685.
28. CIP1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
29. INK4b genes. Oncogene 11: 635-645.
30. RAFF MC, 1996. Size control: the regulation of cell numbers in animal development. Cell 86: 173-175.
31. RUMYANTSEV PP, 1991. In: Rumyantsev PP (ed.). Growth and Hyperplasia of Cardiac Muscle Cells. Harwood Academic Publisher, 70-157.
32. SADOSHIMA J, AOPKI H, IZUMO S, 1997. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of pRb in neonatal cardiomyocytes. Circ Res 80: 228-241.
33. SHERR CJ, 1993. Mammalian G1 cyclins. Cell 73: 1059-1065.
34. SHERR CJ, 1994. G1 phase progression; cycling on cue. Cell 79: 551-555.
35. SHERR CJ, 1996. Cancer cell cycles. Science 274: 1672-1677.
36. SOONPAA MH, KIM KK, PAJAK L, FRANKLIN M, FIELD LJ, 1996. Cardiomyocyte DNA synthesis and multinucleation during murine development. Am J Physiol 271: H2183-H2189.
37. TOYOSHIMA H, HUNTER T, 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67-74.
38. YOSHIZUMI M, LEE WS, HSIEH CM, TSAI JC, LI J, PERRELLA MA, PATTERSON C, ENDEGE WO, SCHLEGEL R, LEE ME, 1995. Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J Clin Invest 95: 2275-2280.
39. KIP2 indicates a role in Beckwith-Weidemann syndrome. Nature 387: 151-158.